Join the club for FREE to access the whole archive and other member benefits.

Dr. Jin Xiong She Talks About NAD IV Infusions and Intracellular Realities (YouTube)

Trial of 10 patients having 5 sessions of intravenous IV saw no increase in icNAD levels

In our 50s and beyond, the NAD level is only about 30% to 50% of the useful level.

NAD deficiency does not necessarily result in any visible signs, because it takes a long time for the NAD deficiency to result in major health issues.

NAD intravenous therapy is quite an expensive procedure and it takes a few hours to complete.

Not seen any published data (i.e. clinical trials) that has evaluated the efficacy or safety of NAD IV therapy, only anecdotal reports.

May have benefits to some patients with very specific conditions such as neurological diseases (e.g. Parkinson's,  Alzheimer) and also addictions .

Did a trial with 10 patients having five sessions, spread over 10 days) of IV infusion with 750 milligrams of NAD in each session.

Intracellular NAD levels didn't increase.

Saw significant (temporary) increase in inflammation biomarker hs-CRP.

NAD too large to get into cells, but could affect immune cells in blood to have some effect.

Also, NAD breaks down in the blood into NAD+ metabolites that posses their own biological functions.

Visit website:

See also: Company Jinfiniti Precision Medicine - Provides at-home intracellular NAD test and other aging blood panels

Mentioned in this Resource

Jin-Xiong She

Founder and CEO, Jinfiniti Precision Medicine and Director of the MCG Center for Biotechnology and Genomic Medicine,

Dr. Jin Xiong She Talks About NAD IV Infusions and Intracellular Realities (YouTube)